rs13440710

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_001099922.3(ALG13):​c.2799T>A​(p.Pro933Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. P933P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0050 ( 0 hom., 1 hem., cov: 9)
Exomes 𝑓: 0.0050 ( 0 hom. 72 hem. )

Consequence

ALG13
NM_001099922.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.799

Publications

4 publications found
Variant links:
Genes affected
ALG13 (HGNC:30881): (ALG13 UDP-N-acetylglucosaminyltransferase subunit) The protein encoded by this gene is a subunit of a bipartite UDP-N-acetylglucosamine transferase. It heterodimerizes with asparagine-linked glycosylation 14 homolog to form a functional UDP-GlcNAc glycosyltransferase that catalyzes the second sugar addition of the highly conserved oligosaccharide precursor in endoplasmic reticulum N-linked glycosylation. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009]
ALG13 Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 36
    Inheritance: XL Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant X-111744771-T-A is Benign according to our data. Variant chrX-111744771-T-A is described in ClinVar as [Likely_benign]. Clinvar id is 412611.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.799 with no splicing effect.
BS2
High Hemizygotes in GnomAdExome4 at 72 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALG13NM_001099922.3 linkc.2799T>A p.Pro933Pro synonymous_variant Exon 24 of 27 ENST00000394780.8 NP_001093392.1 Q9NP73-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALG13ENST00000394780.8 linkc.2799T>A p.Pro933Pro synonymous_variant Exon 24 of 27 2 NM_001099922.3 ENSP00000378260.3 Q9NP73-1

Frequencies

GnomAD3 genomes
AF:
0.00504
AC:
223
AN:
44241
Hom.:
0
Cov.:
9
show subpopulations
Gnomad AFR
AF:
0.0161
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00312
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00642
Gnomad SAS
AF:
0.0117
Gnomad FIN
AF:
0.00480
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00114
Gnomad OTH
AF:
0.00541
GnomAD2 exomes
AF:
0.00296
AC:
84
AN:
28366
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.0105
Gnomad AMR exome
AF:
0.00146
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00524
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00115
Gnomad OTH exome
AF:
0.00331
GnomAD4 exome
AF:
0.00501
AC:
1089
AN:
217287
Hom.:
0
Cov.:
6
AF XY:
0.00120
AC XY:
72
AN XY:
59767
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0280
AC:
135
AN:
4816
American (AMR)
AF:
0.00490
AC:
34
AN:
6935
Ashkenazi Jewish (ASJ)
AF:
0.00134
AC:
4
AN:
2981
East Asian (EAS)
AF:
0.0433
AC:
184
AN:
4252
South Asian (SAS)
AF:
0.0142
AC:
112
AN:
7913
European-Finnish (FIN)
AF:
0.0124
AC:
83
AN:
6681
Middle Eastern (MID)
AF:
0.00722
AC:
4
AN:
554
European-Non Finnish (NFE)
AF:
0.00272
AC:
475
AN:
174518
Other (OTH)
AF:
0.00672
AC:
58
AN:
8637
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.304
Heterozygous variant carriers
0
70
140
209
279
349
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00504
AC:
223
AN:
44251
Hom.:
0
Cov.:
9
AF XY:
0.000114
AC XY:
1
AN XY:
8753
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0161
AC:
158
AN:
9830
American (AMR)
AF:
0.00311
AC:
10
AN:
3215
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
1228
East Asian (EAS)
AF:
0.00641
AC:
9
AN:
1403
South Asian (SAS)
AF:
0.0118
AC:
7
AN:
593
European-Finnish (FIN)
AF:
0.00480
AC:
7
AN:
1459
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
113
European-Non Finnish (NFE)
AF:
0.00114
AC:
29
AN:
25445
Other (OTH)
AF:
0.00534
AC:
3
AN:
562
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.311
Heterozygous variant carriers
0
15
30
45
60
75
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Developmental and epileptic encephalopathy, 36 Benign:3
Dec 01, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Mar 16, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Jun 23, 2020
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

ALG13-related disorder Benign:1
Aug 07, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
0.61
DANN
Benign
0.39
PhyloP100
-0.80
PromoterAI
-0.0073
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13440710; hg19: chrX-110987999; COSMIC: COSV52635167; COSMIC: COSV52635167; API